Ingrid A. Holm, MD, MPH

Ingrid A. Holm, MD, MPH, is Professor of Pediatrics at Harvard Medical School and faculty of the Division of Genetics and Genomics at Boston Children’s Hospital (BCH). She received her MD at the University of California, Los Angeles and completed her pediatric residency and fellowships in Genetics and Endocrinology at BCH. In 2003 she completed the Harvard Pediatric Health Services Research Fellowship and received her MPH in Clinical Effectiveness from the Harvard School of Public Health. She received her certificate in Pediatric Bioethics from Children’s Mercy Center for Bioethics in 2018. Dr. Holm is Chair of BCH Institutional Review Board (IRB).

Dr. Holm conducts empirical research on the ethical, legal, and social implications (ELSI) of genomics in pediatrics.  She is co-PI on the “BEACONS-NBS study”, the “Newborn Screening by Whole Genome Sequencing (NBSxWGS) Collaboratory” funded by the NIH Venture Program to integrate genomic sequencing into NBS at 7 public health programs across the US. This study builds on her experience as co-investigator and co-PI of the BabySeq and BabySeq2 projects, respectively, which conducted randomized trials to explore the medical, behavioral, and economic impacts of integrating genomic sequencing into NBS. Dr. Holm also studies rare diseases. She is Associate Director of Robert’s Program for Sudden Unexpected Death in Pediatrics (SUDP) at BCH where she leads NIH-funded studies to identify genetic contributions to SUDP. Dr. Holm studies the ELSI of n-of-one therapies as co-PI and co-investigator on two NHGRI-funded grants. Dr. Holm’s bioethical area of interest is the ELSI of pediatric genomics.